Earnings Call · Q1 FY2024·2024-05-17

Q1 24EPS +43.26%·Rev n/aQ4 23EPS +2.08%·Rev n/aQ3 23EPS +17.70%·Rev n/aQ2 23EPS -7.26%·Rev n/a⚠ consensus missing

Bolt Biotherapeutics, Inc. BOLT

Willie Quinn — Chief Executive Officer

Edith Perez — Chief Medical Officer

Randy Schatzman — Chief Operating Officer

Dawn Colburn — Chief Medical Officer

Michael Alonso — Chief Scientific Officer

+3.4%1d on move date+3.6% vs SPY3d+2.6%5d+20.7%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BOLT calls or request research access.

More BOLT calls Browse calls Request research access